Eris Lifesciences forms JV with MJ Biopharm to enter insulin segment - Business Insights

Breaking

Post Top Ad

Post Top Ad

Friday, December 3, 2021

Eris Lifesciences forms JV with MJ Biopharm to enter insulin segment

Eris MJ Biopharm, the 70:30 joint venture (with Eris holding a 70 per cent stake), would primarily engage in marketing and distribution of human and analogue insulin Read more at: Source

No comments:

Post a Comment

Post Top Ad